SCHEMBL4370126

SCHEMBL4370126

COc1ccc2ccccc2c1O[C]=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.55
NQO1 P15559 1/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
RAB9A P51151 2/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MTNR1A P48039 2/20 0.42
MTNR1B P49286 2/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
NPC1 O15118 1/20 0.41
NISCH Q9Y2I1 1/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
ABCB1 P08183 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9098138 0.86 MAPT (0.50) MAPTNQO1HPGDKDM4EMEN1
SCHEMBL4069376 0.82 ALOX5 (0.45) MAPTHPGDKDM4ERAB9AALDH1A1
SCHEMBL30380487 0.81 MAPT (0.67) MAPTNQO1HPGDKDM4EMEN1
SCHEMBL278576 0.81 MAPT (0.67) MAPTNQO1HPGDKDM4EMEN1
Formaldehyde SCHEMBL28780252 0.80 MAPT (0.60) MAPTNQO1HPGDKDM4EMEN1
SCHEMBL25986546 0.80 MAPT (0.64) MAPTNQO1HPGDKDM4EMEN1
Ammonia Solution, Strong SCHEMBL11476305 0.80 MAPT (0.64) MAPTNQO1HPGDKDM4EMEN1
SCHEMBL2497894 0.79 TSHR (0.48) MAPTHPGDKMT2ARAB9AALDH1A1
Cyanide SCHEMBL29227829 0.77 MAPT (0.60) MAPTNQO1HPGDKDM4EMEN1
SCHEMBL27456613 0.76 MAPT (0.55) MAPTNQO1HPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619003-B2 Process for producing optically active compound JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2009-11-17 US disclosed
US-20060173210-A1 Process for producing optically active compound JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2006-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173210-A1 Process for producing optically active compound ADH5, ADH1A, ADH4 MAPT 3914/4885NQO1 194/4885HPGD 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.